CYP19A1 and breast carcinoma: The SOLAR-1 clinical trial (NCT02437318) (Study Details Study Assessing the Efficacy and Safety of Alpelisib Plus Fulvestrant in Men and Postmenopausal Women With Advanced Breast Cancer Which Progressed on or After Aromatase Inhibitor Treatment.